A new study shows that older adults with type 2 diabetes who start treatment with sodium–glucose cotransporter-2 (SGLT-2) ...

Speakers at the Institute for Value-Based Medicine event held September 18, 2025, in Nyack, New York, spoke about methods of ...

Resmetirom effectively resolves MASH and improves fibrosis, independent of GLP-1 or SGLT2 inhibitor use, in patients with T2DM. Achieving ≥5% weight loss enhances resmetirom's effects on MASH ...

Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) announced clinical data on adipose tissue distribution in non-diabetic patients treated with sotagliflozin will be presented at the 22nd Global Cardio ...

A new study finds a possible association between GLP-1 drugs like semaglutide and chronic cough, though the authors are ...

A new study shows that older adults with type 2 diabetes who start treatment with sodium–glucose cotransporter-2 (SGLT-2) ...

Revenue from excise duties on sugar-sweetened beverages (SSB) has been used to procure medications for diabetes and chronic kidney disease (CKD), says Health Minister Datuk Seri Dr Dzulkefly Ahmad.

A new study shows that older adults with type 2 diabetes who start treatment with sodium–glucose cotransporter-2 (SGLT-2) inhibitors—such as ...

Type 2 diabetes remission is possible with pharmacologic and nonpharmacologic interventions, but more research is needed on ...

The main takeaway is that GLP-1s appear to provide kidney protection in a specific, well-defined population, CKD driven by ...

Experts say we’re in a golden age for treating chronic kidney disease, with new drugs like Ozempic yielding major results. Will dialysis and organ transplants become a thing of the past?